INSIDER
New vaccine may be option for troops with religious concerns
Read full article: New vaccine may be option for troops with religious concernsA COVID-19 vaccine that could soon win federal authorization may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused the other coronavirus vaccines for religious reasons.
Novavax asks EU regulator to clear COVID vaccine for teens
Read full article: Novavax asks EU regulator to clear COVID vaccine for teensThe pharmaceutical developer Novavax says it has asked the European Medicines Agency to extend the authorization of its coronavirus vaccine to children aged 12 to 17 amid a surge of disease across the continent.
Rich countries getting new COVID vaccine before poorer ones
Read full article: Rich countries getting new COVID vaccine before poorer onesThe company behind a COVID-19 vaccine touted as a key tool for the developing world will miss a target for giving doses to the U.N.-backed effort to deliver shots to poorer countries.
Novavax could offer unvaccinated Americans another option, Pfizer asks FDA to allow vaccine for kids under 5
Read full article: Novavax could offer unvaccinated Americans another option, Pfizer asks FDA to allow vaccine for kids under 5There are two major developments involving the COVID-19 vaccines.
Indonesia first to greenlight Novavax COVID-19 vaccine
Read full article: Indonesia first to greenlight Novavax COVID-19 vaccineBiotechnology company Novavax says that Indonesia has given the worldโs first emergency use authorization for its COVID-19 vaccine, which uses a different technology than current shots.
UK to offer new vaccine shots to Novavax trial volunteers
Read full article: UK to offer new vaccine shots to Novavax trial volunteersBritain says it it will offer new vaccinations to thousands of people who volunteered for trials of the Novavax coronavirus vaccine, which has not yet been approved for use in any country.
UK researchers conducting โmix and matchโ COVID-19 vaccine trials
Read full article: UK researchers conducting โmix and matchโ COVID-19 vaccine trialsWeโve heard that COVID-19 vaccines are not mix and match and that both doses are needed from the same vaccine. But a study is underway in the United Kingdom to see if that might be possible or even preferable.
Drugmaker Novavax begins late-stage vaccine trial in UK
Read full article: Drugmaker Novavax begins late-stage vaccine trial in UKLONDON โ U.S.-based Novavax has begun a late stage trial of its potential COVID-19 vaccine in the United Kingdom because the high-level of the coronavirus circulating in the country is likely to produce quick results, the pharmaceutical company said. Novavax plans to test the effectiveness of its vaccine in a trial involving 10,000 people between the ages of 18 and 84, according to a statement issued late Thursday. The trial is being conducted in partnership with the U.K. governmentโs Vaccine Taskforce, which was created in April to help speed the development of a COVID-19 vaccine. The U.K. has already agreed to buy 60 million doses of the Novavax vaccine to ensure it can be distributed as quickly as possible if it is approved by regulators. The government said Friday that participants in the Novavax trial will be drawn from the 250,000 people who have volunteered to take part in COVID-19 vaccine testing through the National Health Serviceโs Vaccine Registry.
Stocks post solid gains as technology shares lead rally
Read full article: Stocks post solid gains as technology shares lead rallyDespite the rally, the S&P 500 still posted its fourth straight weekly loss, extending Wall Street's September swoon. The S&P 500 rose 1.6% after flip-flopping between small gains and losses a few times in the early going. The S&P 500 came within striking distance of a 10% drop from its all-time high earlier this week, what Wall Street calls a correction. The S&P 500 rose 51.87 points to 3,298.46. Norwegian Cruise Line notched the biggest gain in the S&P 500, vaulting 13.7%.
The Latest: Concerns over coronavirus upticks in California
Read full article: The Latest: Concerns over coronavirus upticks in CaliforniaThe directive comes amid concerns about an uptick in coronavirus cases in certain Brooklyn and Queens neighborhoods with large Orthodox Jewish populations. New York Cityโs current overall infection rate remains low, but official figures indicate the affected neighborhoods accounted for 20% of the cityโs coronavirus cases in recent weeks. ___BOSTON โ An outbreak of coronavirus infections at a major Boston hospital has grown to 19 confirmed cases. ___DES MOINES, Iowa โ Iowa has reported a jump of 1,086 new coronavirus cases, the second consecutive day of new cases exceeding 1,000. There are currently nearly 985,000 worldwide coronavirus deaths.
Trump to visit North Carolina, cite work on COVID-19 vaccine
Read full article: Trump to visit North Carolina, cite work on COVID-19 vaccineWASHINGTON The White House says President Donald Trump will visit North Carolina on Monday to tour a business that is participating in work on a COVID-19 vaccine. The White House said Trump is expected to speak about the collaboration between the administration and the private sector to rapidly develop a vaccine and ensure rapid distribution once ready. North Carolina is a key battleground state in the coming election, and Trumps visit marks his 10th trip to the state during his presidency. The biotechnology facility Trump will visit is the FUJIFILM Diosynth Biotechnologies Innovation Center in Morrisville, a suburb of Raleigh. The White House said the company is manufacturing key components of a COVID-19 vaccine candidate being developed by Novavax, an American vaccine development company based in Maryland.
US company trials coronavirus vaccine candidate in Australia
Read full article: US company trials coronavirus vaccine candidate in AustraliaIn this photo released by Nucleus Network/ABC, clinical trial participants are given a coronavirus vaccine in Melbourne, Australia, Tuesday, May 26, 2020, with hopes of releasing a proven vaccine this year. Novavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and looking for signs of its effectiveness. (Patrick Rocca/Nucleus Network/ABC via AP)CANBERRA A U.S. biotechnology company began injecting a coronavirus vaccine candidate into people in Australia on Tuesday with hopes of releasing a proven vaccine this year. Novavax used genetic engineering to grow harmless copies of the coronavirus spike protein in giant vats of insect cells in a laboratory. The way we make a vaccine is we never touch the virus, Novavax told The Associated Press last month.